Table 2. IOP measurements in the study groups at different follow-up visits.

Time	POAG	PXFG	1P
Baseline
No. of eyes	28	20
Value	22.9±3.7	25.7±4.4	0.02
1d
No. of eyes	28	20
Value	17.8±5.1	14.7±4.3	0.03
Change	-5.2±5.0	-11±5.3	<0.001
Change %	-22±20	-42±18	<0.001
1wk
No. of eyes	23	20
Value	19.8±3.6	18.7±4.2	0.33
Change	-3.2±3.2	-7.1±6.2	0.01
Change %	-13±13	-26±21	0.02
1mo
No. of eyes	27	20
Value	18.4±4.9	17.7±4.3	0.61
Change	-4.5±4.0	-7.9±5.6	0.02
Change %	-20±18	-30±19	0.04
3mo
No. of eyes	28	20
Value	18.1±2.7	17.0±3.4	0.22
Change	-4.8±3.0	-8.7±5.8	0.005
Change %	-20±11	-32±19	0.009
6mo
No. of eyes	28	20
Value	18.4±3.2	17.9±4.0	0.62
Change	-4.6±3.0	-7.8±5.5	0.01
Change %	-19±11	-29±17	0.02
9mo
No. of eyes	23	17
Value	17.9±3.3	16.3±1.0	0.96
Change	-4.9±3.5	-6.7±2.9	0.30
Change %	-21±13	-28±11	0.22
12mo
No. of eyes	18	15
Value	18.0±3.9	21.0±6.6	0.32
Change	-3.5±4.2	-4.7±9.3	0.75
Change %	-16±17	-16±32	0.9

POAG: Primary open angle glaucoma; PXFG: Pseudoexfoliative glaucoma. ¹t-test.

x±s